Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant DNA-based hyaluronidase

hyaluronidase, recombinant
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant DNA-based hyaluronidase, covering 2017-05-16 to 2017-05-16. Get the full timeline:

Most recent: Clinical Trial Update: The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers [Phase 1]

See pricing